On April 26 a Los Angeles jury awarded a plaintiff $6.5 million in a case arising from the use of Actos, a diabetes drug. The plaintiff claimed that the bladder cancer and death of her husband was due to ingesting Actos. The jury found that the Japanese drugmaker Takeda Pharmaceutical did not provide adequate bladder-cancer warnings to Cooper and his doctors.
Actos (pioglitazone), a prescription drug sold by Takeda, is used to treat Type 2 diabetes. It works to balance blood sugar by increasing cells' receptiveness to insulin. A similar drug is called ActoplusMet which combines metformin. Actos was responsible for $3.4 billion in sales for Takeda in 2009.
If you or a loved one have been diagnosed with bladder cancer and would like a free consultation on your potential legal rights regarding Actos please contact attorney David Bryant at (502) 882-6000 or email@example.com.